Dip Buying Opportunities | Cannabis Daily September 27, 2021

Cannabis Daily

BENZINGA CANNABIS CAPITAL CONFERENCE

The premier gathering of cannabis entrepreneurs and investors in North America returns for a 2-Day Hybrid Event on October 14-15.

Speakers will include $SNDL and other major Cannabis Companies, for more information visit https://www.benzinga.com/events/cannabis/

Welcome to Cannabis Daily - Your daily guide to cannabis news, industry trends and trade ideas in under 5 mins.

• Subscribe to all Benzinga Podcasts at https://www.benzinga.com/podcasts

• Subscribe to the Cannabis Insider Newsletter to get more cannabis news and trending links delivered to your inbox.

• Tune in daily to Cannabis Hour at 4:30 p.m. ET for Cannabis News at bzcannabishour.com.

Hit us up at https://www.benzinga.com/cannabis/ for more news today, tomorrow, and everyday.

Episode Summary

The house committee will vote on federal marijuana legalization bill.

Massive oversupply problem, especially in California. The price drops for products are driving a lot of craft growers and smaller farms to a breaking point.

Public companies talked about on the show:

• ARCA:MSOS
• OTC:AAWH
• OTC:AUSAF
• OTC:DLTNF
• OTC:VVCIF
• OTC:ITHUF
• OTC:BILZF
• CNSX:BHNG

Hosted & Produced By:

Elliot Lane

Aaron Thomas

Contact us at: [e-mail]

Follow Benzinga Cannabis On Social Media

• Instagram
• Twitter
• YouTube
• LinkedIn

Access All The Cannabis Daily Episodes Here

Also Join us at the Benzinga Cannabis Hour Podcast, weekly on Thursdays at 4 PM EST.

For Top Gainers & Losers Cannabis stocks of the day check out https://www.benzinga.com/cannabis/stocks

NOT FINANCIAL ADVICE

The Information Contained on this Podcast is not intended as, and shall not be understood or construed as, financial advice

Unedited Transcript:

Monday morning friends, WhatsApp. This is Elliot lane with cannabis daily. Hope you all had a very restful, relaxing and or fun and party filled weekend, whatever you want. I hope you had it. Uh, but it is Monday. We are back to making money, especially when we come to. Investing in cannabis. There's a lot to talk about today.

So let's dive right in a M S O S. That is the advisor shares. ETF is the talk of the town right now. Uh, they saw a double bottom they're at a record high 27.21 million shares and is at 342% year over year. Their volume has been fantastic over the past week. Uh, so keep an eye on them. Uh, I'm liking. A trend that we're seeing from, from him S uh, and if that is reflective of the industry, this could be a great week for cannabis stocks.

So, uh, very excited to see how that continues this week. Uh, I would definitely put them on your watch list if not throw a share into your mix, the good broad term. Unanimously approved legislation that will allow to tap opportunities in the growing market for medicinal cannabis, a little more, uh, international cannabis news, piggybacking off the wonderful Aaron Thomas from Friday, uh, some domestic news though on the political side, the house committee will vote on federal marijuana legalization bill.

Next week, days after banking reform advances. This is exciting. This is the more active they are voting. I absolutely do not expect this to go anywhere. Uh, the safe act is what we're focusing on right now. Um, from my understanding, this is more of a markup, more of a let's talk about it. Let's let's compromise again.

Let's see where we can go. Uh, and we'll see where it comes. Uh, this, but this bill would remove cannabis as a scheduled drug, allow those with marijuana convictions to have their records expunged and allow a federal tax on marijuana. Ideally replacing 2 88 and I, which hopefully safe would do as well.

Jackie Bryant from high times reports on massive oversupply problem, especially in California, the price drops. Four products are driving a lot of craft growers and smaller farms to a breaking point. Now this will eventually affect the little farms, the parent companies, the vibe bio-sciences and a few others.

But, uh, right now they are able to survive something like this. But this is an issue to keep an eye on, especially for the California operators of wellness. That's a w H reaches a milestone of 1 million. In contributions to the last prisoner project, uh, one of the major, uh, advocacy groups for decriminalizing and legalizing marijuana, uh, and, and helping right, the wrongs, uh, that criminalizing marijuana has done too many throughout this.

Uh, audacious brands, a U S a F beginning, a $15 million capital raise. I do not expect that to take them long. They have an incredible management team. Terry Booth, one of the original Aurora cannabis, uh, executive teams, mark clockmaker and incredible IRR person in this. Uh, John Paul and a few others. Uh, so I expect that to go relatively quickly for them stem holdings, that's driven by stem expands, a California e-commerce and delivery footprint with new distribution hub license, perhaps news, like this will help the oversupply problem.

And in terms of, uh, expanding the. Um, the consumer reach for the supply problem. Uh, so we'll see if hopefully more news like this can, uh, can help these younger craft growers get their products out. Delta nine, DLT and F announces S supply partnership agreement with vivo cannabis, giving them access to vivos 20,000 medical cannabis patients.

Delta nine has been on the move recently, very much enjoying the visibility we're seeing for them, vivo cannabis, quite the opposite, uh, to, to me pre COVID, they were a darling of the Canadian cannabis industry. Uh, they were one of the first movers in e-commerce and then, um, nothing, I haven't heard much out of them at all.

So, uh, Delta nine and vivo, uh, I enjoy this partnership. I think two strong companies, but vivo, I think, uh, has some ground to make. Uh, but perhaps to Delta nine, John R Beth, not Ian Chatsy and team over there looking at price performance. Um, over the past week, month and three months, I ant this continues to be the three-month leader with 110 and a half percent growth over three months in credible ignite international brands.

That's Dan Bilzerian is brand, uh, not too far behind 105 and a half percent. How, uh, it felt keep that Dan Bilzerian is known to just do what he wants, but, uh, we'll, we'll see, uh, looking in the shorter term, even co that's a Canadian operator Eve, uh, is at 50% on the week, uh, on the month, you're looking at MGC pharmaceuticals at 45% on the loser side.

It's unfortunate because they were once one of my favorite stocks, but next screen. Down 27.9% over the line last month. Hexo one of the big losers over the three. Bang. Uh, this is an interesting one for me, 16.7% down over the last week, but they did just announce a major partnership, uh, with Belushi farms.

So, uh, that is something that I would say this might be a dip buying opportunity for bang B H and G specifically. Uh, this is Elliot lane with cannabis daily, lots to talk about today. I hope you got a lot out of it. A lot to look. Uh, over the next few days, uh, pay attention to us. Uh, benzinga.com/cannabis, uh, cannabis, our cannabis insider every week.

We love bringing you this news. Let us know how we can improve until tomorrow. Y'all.

Support this podcast at — https://redcircle.com/cannabis-daily/donations
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy